Yanqiu Zhao

A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial

Yuxiang Ma, Yunpeng Yang, Yan Huang et al. · Nature Medicine · 2025 · 76 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and Safety of Taletrectinib in Chinese Patients With <i>ROS1+</i> Non–Small Cell Lung Cancer: The Phase II TRUST-I Study

Wěi Li, Anwen Xiong, Nong Yang et al. · Journal of Clinical Oncology · 2024 · 34 citations · Full text

Medicine, Oncology, Pharmacology +12

Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial

Yuankai Shi, Jian Fang, Ligang Xing et al. · Nature Medicine · 2025 · 28 citations

Medicine, Molecular Genetics, Oncology +13

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial

Zhiwei Chen, Fang Yang, Jiang Zhou et al. · The Lancet · 2025 · 28 citations

Medicine, Oncology, Pharmacology +10

Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study

Yongfeng Yu, Qisen Guo, Yongchang Zhang et al. · The Lancet Respiratory Medicine · 2024 · 21 citations

Medicine, Oncology, Pharmacology +12